Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Edelstein

Showing results (301-310 of 420) with videos related to

Pageof 42
Sort By:
Kidney International|March 1, 1996
Arachidonic acid protects against hypoxic injury in rat proximal tubulesA M Alkhunaizi, M M Yaqoob, C L Edelstein, et al.
BMC Oral Health|May 8, 2021
Protocol for a family-centered behavioral intervention to reduce early childhood caries: the MySmileBuddy program efficacy trialChristie L Lumsden, Burton L Edelstein, Charles E Basch, et al.
Journal of Public Health Dentistry|October 7, 2015
Validation of an early childhood caries risk assessment tool in a low-income Hispanic populationChristie L Custodio-Lumsden, Randi L Wolf, Isobel R Contento, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 1999
Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney diseaseT Ecder, C L Edelstein, A B Chapman, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 1, 1987
Clinical application of thermal isoeffect doseM W Dewhirst, J M Winget, L Edelstein-Keshet, et al.
Obesity (Silver Spring, Md.)|February 27, 2010
Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention programJonathan Krakoff, Jeanne M Clark, Jill P Crandall, et al.
BMC Nephrology|August 2, 2013
Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney diseaseJelena Klawitter, Iram Zafar, Jost Klawitter, et al.
Diabetes Care|March 29, 2005
Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participantsRichard R Rubin, William C Knowler, Yong Ma, et al.
American Journal of Physiology. Renal Physiology|May 2, 2019
A study of sirolimus and mTOR kinase inhibitor in a hypomorphic <i>Pkd1</i> mouse model of autosomal dominant polycystic kidney diseaseSara J Holditch, Carolyn N Brown, Daniel J Atwood, et al.
BMJ Open Diabetes Research & Care|October 7, 2020
Long-term metformin adherence in the Diabetes Prevention Program Outcomes StudyElizabeth Arquin Walker, Jeffrey S Gonzalez, Mark T Tripputi, et al.
Pageof 42

Showing results (301-310 of 420) with videos related to

Sort By:
Pageof 42
Kidney International|March 1, 1996
Arachidonic acid protects against hypoxic injury in rat proximal tubulesA M Alkhunaizi, M M Yaqoob, C L Edelstein, et al.
BMC Oral Health|May 8, 2021
Protocol for a family-centered behavioral intervention to reduce early childhood caries: the MySmileBuddy program efficacy trialChristie L Lumsden, Burton L Edelstein, Charles E Basch, et al.
Journal of Public Health Dentistry|October 7, 2015
Validation of an early childhood caries risk assessment tool in a low-income Hispanic populationChristie L Custodio-Lumsden, Randi L Wolf, Isobel R Contento, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 1999
Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney diseaseT Ecder, C L Edelstein, A B Chapman, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 1, 1987
Clinical application of thermal isoeffect doseM W Dewhirst, J M Winget, L Edelstein-Keshet, et al.
Obesity (Silver Spring, Md.)|February 27, 2010
Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention programJonathan Krakoff, Jeanne M Clark, Jill P Crandall, et al.
BMC Nephrology|August 2, 2013
Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney diseaseJelena Klawitter, Iram Zafar, Jost Klawitter, et al.
Diabetes Care|March 29, 2005
Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participantsRichard R Rubin, William C Knowler, Yong Ma, et al.
American Journal of Physiology. Renal Physiology|May 2, 2019
A study of sirolimus and mTOR kinase inhibitor in a hypomorphic <i>Pkd1</i> mouse model of autosomal dominant polycystic kidney diseaseSara J Holditch, Carolyn N Brown, Daniel J Atwood, et al.
BMJ Open Diabetes Research & Care|October 7, 2020
Long-term metformin adherence in the Diabetes Prevention Program Outcomes StudyElizabeth Arquin Walker, Jeffrey S Gonzalez, Mark T Tripputi, et al.
Pageof 42